Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK.
J P SevillaDaniel TortoriceDavid KantorJohn ReganKinga H MeszarosEkkehard C BeckNajida BegumDavid E BloomPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2024)
HALM-based CBA provides an empirically richer, more utility-theoretically grounded approach to vaccine evaluation than CUA, demonstrating good value for money for legislatures (based on private values) and for all decision-makers (based on social values).